X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (109) 109
index medicus (93) 93
gastroenterology & hepatology (91) 91
hepatitis b (66) 66
male (64) 64
female (63) 63
middle aged (58) 58
antiviral agents - therapeutic use (56) 56
adult (50) 50
hepatitis b, chronic - drug therapy (48) 48
hepatitis (45) 45
lamivudine (42) 42
gastroenterology and hepatology (41) 41
hepatitis b virus (38) 38
liver (38) 38
tenofovir (38) 38
aged (33) 33
interferon (32) 32
cirrhosis (31) 31
therapy (31) 31
entecavir (30) 30
antiviral agents (26) 26
hepatocellular carcinoma (25) 25
treatment outcome (25) 25
hepatitis c virus (23) 23
adenine - analogs & derivatives (22) 22
hepatitis b virus - genetics (22) 22
infection (22) 22
patients (22) 22
care and treatment (21) 21
hepatitis b e antigens - blood (21) 21
liver cirrhosis (21) 21
guanine - analogs & derivatives (20) 20
interferon-alpha - therapeutic use (20) 20
dna, viral - blood (19) 19
hepatitis c (19) 19
chronic hepatitis b (18) 18
hepatology (18) 18
natural-history (18) 18
pharmacology & pharmacy (18) 18
deoxyribonucleic acid--dna (17) 17
efficacy (17) 17
fibrosis (17) 17
hepatitis b virus - immunology (17) 17
hepatocellular-carcinoma (17) 17
adenine - therapeutic use (16) 16
antiviral agents - administration & dosage (16) 16
hbsag (16) 16
lamivudine - therapeutic use (16) 16
risk factors (16) 16
hbv (15) 15
health aspects (15) 15
hepatitis b surface antigens - blood (15) 15
hepatitis b, chronic - complications (15) 15
liver cancer (15) 15
liver diseases (15) 15
organophosphonates - therapeutic use (15) 15
polyethylene glycols - therapeutic use (15) 15
transplantation (15) 15
virological response (15) 15
virus infection (15) 15
adefovir dipivoxil (14) 14
analysis (14) 14
combination (14) 14
development and progression (14) 14
drug therapy, combination (14) 14
hepatitis b surface antigen (14) 14
management (14) 14
antigens (13) 13
biological response modifiers (13) 13
hepatitis b - drug therapy (13) 13
hepatitis b virus - drug effects (13) 13
liver - pathology (13) 13
safety (13) 13
antiviral agents - adverse effects (12) 12
biopsy (12) 12
disease progression (12) 12
follow-up studies (12) 12
guanine - therapeutic use (12) 12
hepatitis b, chronic - immunology (12) 12
liver transplantation (12) 12
recombinant proteins - therapeutic use (12) 12
retrospective studies (12) 12
time factors (12) 12
virology (12) 12
antiviral therapy (11) 11
cancer (11) 11
cohort studies (11) 11
drug resistance (11) 11
hepatitis b e antigen (11) 11
hepatitis c, chronic - drug therapy (11) 11
medical research (11) 11
medicine, experimental (11) 11
peginterferon alpha-2a (11) 11
risk (11) 11
transient elastography (11) 11
viruses (11) 11
abridged index medicus (10) 10
hbv dna (10) 10
hepatitis b, chronic - blood (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 10/2019
Journal Article
Gut, ISSN 0017-5749, 04/2015, Volume 64, Issue 4, pp. 526 - 528
  Treatment efficacy is in fact unquestioned as more than 95% of patients, including NUC experienced and resistant ones, achieve complete suppression of viral... 
ENTECAVIR | DURABILITY | HBSAG | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | TENOFOVIR | Humans | Studies | Hepatitis | Liver diseases | Physicians | Liver cirrhosis | Patients | Deoxyribonucleic acid--DNA
Journal Article
Hepatology, ISSN 0270-9139, 08/2018, Volume 68, Issue 2, pp. 397 - 400
Journal Article
Journal of Hepatology, ISSN 0168-8278, 09/2019, Volume 71, Issue 3, pp. 453 - 455
Journal Article
Gut, ISSN 0017-5749, 12/2016, Volume 65, Issue 12, pp. 1998 - 2006
Journal Article
Gastroenterology, ISSN 0016-5085, 11/2013, Volume 145, Issue 5, p. 1155
Journal Article
Gastroenterology and Hepatology, ISSN 1554-7914, 10/2013, Volume 9, Issue 10, pp. 656 - 658
Journal Article
Journal Article
Journal Article
Liver International, ISSN 1478-3223, 12/2018, Volume 38, Issue 12, pp. 2190 - 2198
Background & Aims Advances in direct‐acting antiviral treatment of HCV have reinvigorated public health initiatives aimed at identifying affected individuals.... 
HCV | chronic infection | linkage to care | WHO | VIRUS-INFECTION | RISK-FACTORS | NATIONAL PROGRESS | UNIVERSAL | PREVALENCE | GENERAL-POPULATION | INJECT DRUGS | PEOPLE | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | HCV-INFECTION | Antiviral agents | Evaluation | Hepatitis C virus | Hepatitis C | Analysis | Hepatitis | Screening | Liver diseases | Liver | Strategy | Birth | Icebergs | Patients | Public health | Viral Hepatitis
Journal Article